TrialFrontiers in immunology2026

Lanadelumab safety, efficacy, and pharmacokinetics in patients aged ≥12 with hereditary angioedema in China: an open-label, multicenter study.

Yuxiang Zhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.